NDC 73377-215-01 - sorafenib Tosylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-215
- Requested NDC
- 73377-215-01
- Package NDCs from labels
- 73377-215-01, 73377-215-02, 73377-215-03
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2023-08-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| sorafenib Tosylate - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2023-08-29 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-215-01 | sorafenib Tosylate | 1000 g in 1 JAR | POWDER | 1000 | 2 | |
| 73377-215-02 | sorafenib Tosylate | 500 g in 1 JAR | POWDER | 500 | 2 | |
| 73377-215-03 | sorafenib Tosylate | 350 g in 1 JAR | POWDER | 350 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sorafenib Tosylate | SORAFENIB | Mylan Pharmaceuticals Inc. | b7919013-1511-44f0-a759-3fa78a9fa178 | 2026-03-18 | Warnings, Adverse reactions | 5T62Q3B36J |
| sorafenib | SORAFENIB | Dr.Reddys Laboratories Inc | 93f9c3b2-d4c5-80d3-5421-8b4c29fbf8a6 | 2024-12-02 | Warnings, Adverse reactions | 5T62Q3B36J |
| Sorafenib | SORAFENIB | Teva Pharmaceuticals, Inc. | dae598f7-823f-405c-ae31-f924594187b9 | 2022-07-01 | Warnings, Adverse reactions | 5T62Q3B36J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.